PharmAust Completes Cohort 3 Pharmacokinetics in MND Patients Category: News and Announcements 2023By PharmAust09/08/2023Related postsData from Canine Oncology Study Supports Progression to Registration Studies19/10/2023Chief Executive Officer Appointment28/08/2023Additional Phase 1 data suggest MPL may inhibit MND22/08/2023Appendix 4C and Quarterly Update31/07/2023MND Trial Successfully Completes 3rd Patient Cohort28/07/2023Canine Trial Update13/07/2023
